AstraZeneca PLC (AZN)

201.76 -1.97 (-0.97%) USD  |  NYSE  |  Mar 03, 16:00
202.33 +0.57 (+0.28%) Pre-Market: 06:01
More

AstraZeneca Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for AZN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
GSK Plc Upgrade
Mereo BioPharma Group Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Biodexa Pharmaceuticals Plc --
Bicycle Therapeutics Plc Upgrade